"" No More: An Analysis of Antibacterial Cyclotides.

The emergence of rapidly evolving multidrug-resistant pathogens and a deficit of new compounds entering the clinical pipeline necessitate the exploration of alternative sources of antimicrobial therapeutics. Cyclotides revealed in . are a class of highly stable, cyclic, and disulfide-bound peptides with diverse intrinsic bioactivities.